Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Pfizer leads Big Pharma's emerging markets growth as GlaxoSmithKline, Eli Lilly lag
Pfizer leads Big Pharma's emerging markets growth as GlaxoSmithKline, Eli Lilly lag
Pfizer leads Big Pharma's emerging markets growth as GlaxoSmithKline, Eli Lilly lag
Submitted by
admin
on September 20, 2017 - 11:08pm
Source:
Fierce Pharma
News Tags:
Pfizer
GSK
Eli Lilly
emerging markets
Headline:
Pfizer leads Big Pharma's emerging markets growth as GlaxoSmithKline, Eli Lilly lag
Do Not Allow Advertisers to Use My Personal information
